Filter
2149
Filtered Results: 2149
Text search:
Italy
Featured
Recommendations
199
New Publications
355
Language
Document type
No document type
1008
Studies & Reports
492
Guidelines
283
Manuals
123
Fact sheets
63
Strategic & Response Plan
61
Training Material
39
Situation Updates
28
Brochures
14
Resource Platforms
12
Infographics
9
Online Courses
8
Videos
7
Dashboards/Maps
1
App
1
Countries / Regions
Western and Central Europe
133
Global
110
Latin America and the Carribbean
42
Ukraine
39
India
34
Germany
34
Syria
34
Eastern Europe
34
Italy
34
Myanmar / Burma
32
Russia
32
Eastern Europe and Central Asia
25
Ethiopia
23
Mozambique
23
Africa
22
Kenya
21
Brazil
21
Venezuela
18
Sierra Leone
17
Liberia
17
Nigeria
16
Yemen
16
Argentina
15
South Africa
13
West and Central Africa
13
Middle East and North Africa
13
South Sudan
12
Bangladesh
12
Colombia
12
Congo, Democratic Republic of
11
Indonesia
11
Paraguay
11
Guinea
10
Turkey
10
Angola
10
Spain
10
Uganda
9
Tanzania
9
Eswatini/ Swaziland
9
Madagascar
9
East and Southern Africa
9
Vietnam
9
Philippines
8
Burkina Faso
7
Lebanon
7
Rwanda
7
Malawi
7
Asia
7
Albania
7
Portugal
7
Ghana
6
Haiti
6
Somalia
6
Nepal
6
China
6
Sudan
6
Central African Republic
6
Bolivia
6
Greece
6
South–East Asia Region
6
Poland
6
Senegal
5
Zambia
5
Libya
5
Moldova
5
Mali
4
Cameroon
4
Niger
4
Iraq
4
Jordan
4
Afghanistan
4
Cambodia
4
Switzerland
4
Hungary
4
Chile
4
Palestine
4
Romania
4
Guinea-Bissau
3
USA
3
Zimbabwe
3
Egypt
3
Benin
3
Ecuador
3
Tajikistan
3
United Kingdom
3
Côte d’Ivoire / Ivory Coast
2
Pakistan
2
Chad
2
Gambia
2
Ireland
2
Peru
2
North Macedonia
2
Croatia
2
Botswana
2
Laos
2
Uruguay
2
Denmark
2
France
2
Tunisia
2
Belarus
2
Thailand
1
Malaysia
1
Mauritania
1
Namibia
1
Serbia
1
Honduras
1
Slovenia
1
El Salvador
1
Lesotho
1
Mexico
1
Sri Lanka
1
Western Pacific Region
1
Djibouti
1
Armenia
1
Congo-Brazzaville
1
Estonia
1
Iran
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
Georgia
1
Turkmenistan
1
Japan
1
Mauritius
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
508
Clinical Guidelines
156
Public Health
106
Women & Child Health
83
Key Resources
78
Pharmacy & Technologies
29
Capacity Building
25
Toolboxes
COVID-19
366
Mental Health
306
Refugee
127
HIV
127
TB
117
Disability
111
Planetary Health
105
Conflict
75
AMR
69
Rapid Response
65
NTDs
50
Global Health Education
42
Pharmacy
40
Ebola
38
Health Financing Toolbox
36
Caregiver
34
Natural Hazards
33
NCDs
30
Zika
25
Specific Hazards
16
Social Ethics
14
Polio
2
Typhoon
2
Cholera
1
Development assistance for health (DAH) has grown substantially, totaling more than $31.3 billion in 2013. However, the degree that countries with high concentrations of armed conflict, ethnic violence, inequality, debt, and corruption have received this health aid and how that assistance might be d...
WHO-OHCHR launch new guidance to improve laws addressing human rights abuses in mental health care
Ahead of World Mental Health Day, the World Health Organization (WHO) and the Office of the High Commissioner on Human Rights (OHCHR) are jointly launching a new guidance, entitled "Mental health, h...
In In recent years, China has increased its international engagement in health. Nonetheless, the lack
of data on contributions has limited efforts to examine contributions from China. Existing estimates that track
development assistance for health (DAH) from China have relied primarily on one data...
Development assistance for health (DAH) is an important part of financing healthcare in low- and middle-income countries. We estimated the gross disbursement of DAH of the 29 Development Assistance Committee (DAC) member countries of the Organisation for Economic Co-operation and Development (OECD) ...
A global Pandemic, Preparedness and Response (RRR) architecture
A year ago, the second Special Session of the World Health Assembly (WHASS) unanimously agreed to start a diplomatic process for a new binding instrument aimed at ensuring the international community is better prepared for the next health emergencies. The establishment of an Intergovernmental Negoti...
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si...
As the Group of Eight (G8) world leaders meet in Saint Petersburg, Russia for this year’s G8 Summit, it is important to take stock of international efforts to finance the response to the global HIV/AIDS epidemic. Financing a sufficient and sustained response to the epidemic has emerged as one of t...
This report provides an analysis of donor government funding to address the HIV response in low- and
middle-income countries in 2022, the latest year available, as well as trends over time. It includes both
bilateral funding from donors and their contributions to the Global Fund to Fight AIDS, Tub...
The annual Development Co-operation Report brings new evidence, analysis and ideas on
sustainable development to members of the OECD Development Assistance Committee (DAC) and the international community more broadly. The objectives are to promote best practices and innovation in development co-ope...
Objective: To identify gaps in national stroke guidelines that could be bridged to enhance the quality of stroke care services in low- and
middle-income countries.
Methods: We systematically searched medical databases and websites of medical societies and contacted international organizations.
Co...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
Since the discovery of insulin nearly 100 years ago, advances in diabetes treatments and therapies have transformed the lives of people
with diabetes (PwD), notably reducing the daily burden of its management.
Newer technologies, including those driven by artificial intelligence, have the potentia...
In spite of the work carried out by the EU institutions, the Member States, many cities and grassroot movements in Europe, the general public is still not engaging enough in air quality policy initiatives and the level of awareness and knowledge of the effects of poor air quality on health is often ...
The far-reaching impacts of the COVID-19 pandemic underscore the critical need for evidence-informed, transparent and inclusive decision-making. Policy-makers have grappled with complex choices amidst uncertainty. They have constantly reassessed response measures while navigating their economic impl...
The Global Status Report on Noncommunicable Diseases (NCDs) 2014 by the World Health Organization outlines the global impact of NCDs, including cardiovascular diseases, cancer, diabetes, and chronic respiratory diseases, which are responsible for a significant portion of global mortality, particular...
This global status report on prevention and control of NCDs (2014), is framed around the nine voluntary global targets. The report provides data on the current situation, identifying bottlenecks as well as opportunities and priority actions for attaining the targets. The 2010 baseline estimates on N...
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022). Countries are responding to the World Health Organization (WHO) call t...
Chronic kidney disease (CKD) is an important contributor to mortality from noncommunicable diseases. No decrease has been seen for CKD mortality contrary to many other important non-communicable diseases (e.g., cardiovascular disease). The prevalence of CKD and kidney failure are increasing all over...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
